Publications by authors named "Tamar Rukhadze"
Article Synopsis
- In 2015, Georgia started a program to eliminate Hepatitis C (HCV) using sofosbuvir, a medication effective for all genotypes, especially for patients with advanced liver disease.
- A study analyzed treatment outcomes for 1,525 patients with HCV genotype 3 and advanced liver fibrosis; those treated with a 24-week sofosbuvir/ribavirin regimen achieved a 79.3% cure rate, while those on a 12-week sofosbuvir/pegylated interferon/ribavirin regimen had a 96.5% cure rate.
- Females and younger patients (aged 31-45) were more likely to achieve a sustained viral response (SVR
